Drug prices The most recent policy would empower Medicare to negotiate the cost for 10 of the most expensive drugs by 2025 and 20 drugs per year by 2028. (Photo: Shutterstock)

After months of haggling, congressional Democrats on Tuesday reached a scaled-back agreement on drug pricing reform. The proposal would allow Medicare Part D to negotiate directly with pharmaceutical companies.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.